CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | Stock-Healthcare | 71.42% | -21.90% | — | |
| 2 | RUBYUSD | Rubius Therapeutics INC | Stock-Other | 7.99% | — | — | |
| 3 | DNLI | Denali Therapeutics INC | Stock-Other | 6.55% | — | — | |
| 4 | KLDO | Kaleido Biosciences INC | Stock-Other | 5.00% | — | — | |
| 5 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 3.61% | — | — | |
| 6 | ✓ | Evelo Biosciences INC | Stock-Other | 3.21% | — | — | |
| 7 | ✓ | Axcella Health INC Com New | Stock-Other | 1.40% | — | — | |
| 8 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 0.82% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | +15.8% | — | Unchanged |
| 2 | KLDO | Kaleido Biosciences INC | +0.1% | — | Unchanged |
| 3 | SYRSEUR | Syros Pharmaceuticals INC | -0.3% | — | Unchanged |
| 4 | MCRB1EUR | Seres Therapeutics INC | -0.6% | — | Unchanged |
| 5 | ✓ | Axcella Health INC Com New | -0.6% | — | Unchanged |
| 6 | ✓ | Evelo Biosciences INC | -0.9% | — | Unchanged |
| 7 | DNLI | Denali Therapeutics INC | -1.2% | — | Unchanged |
| 8 | RUBYUSD | Rubius Therapeutics INC | -12.4% | — | Unchanged |
| 9 | TMDX | Transmedics Group INC | — | — | Unchanged |